Superdisintegrants Market Size, Share & Trends Analysis Report By Product | Forecast to 2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Will The Superdisintegrants Market Valuation Change Between Now And 2029?
In recent years, the superdisintegrants market has exhibited robust growth. The market size, which currently stands at $1.09 billion in 2024, is expected to surge to $1.16 billion by 2025, representing a compound annual growth rate (CAGR) of 6.2%. This historic growth trend can be linked to factors such as the surging frequency of chronic and lifestyle-related health conditions, expansion in the global pharmaceutical sector, escalating demand for orally disintegrating tablets (ODTs), an expanding elderly and young population base, and an enhanced emphasis on the bioavailability of drug enhancement.
The market size of superdisintegrants is anticipated to experience significant expansion in the coming years, potentially reaching a size of $1.47 billion in 2029, with a compound annual growth rate (CAGR) of 6.1%. The expected growth during the forecasting period is credited to the increasing need for oral solid dosage forms, the rise in chronic diseases, the expansion of pharmaceutical manufacturing, and a heightened prevalence of chronic health conditions. The future trends to watch in this period encompass technological improvements in production, advancements in co-processed excipients leaning toward natural and biodegradable superdisintegrants, the development of innovative drug delivery systems, and collaboration between excipient and pharmaceutical companies.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21292&type=smp
What Underlying Factors Are Supporting The Superdisintegrants Market Growth?
The growth of the superdisintegrants market is anticipated to be fueled by an increase in the production of generic drugs. Generic drugs are medications that have the same active ingredients, dosage, strength, administration method, quality, and effectiveness as brand-name drugs, but are usually less expensive. The driving factor behind the increase in generic drug production is the growing demand for reasonably priced medicines, the expiration of patents on branded drugs, and initiatives taken by the governments to decrease healthcare costs. Superdisintegrants serve a key role in generic drugs by enhancing tablet disintegration and dissolution, which ensures quicker drug release, better bioavailability, and increased patient adherence. For example, a report released by the Food and Drug Administration, a government agency in the United States, in January 2023 showed that 91% of prescriptions in the country were filled using generic drugs in 2022. Over 32,000 generic medications have been confirmed by the Food and Drug Administration to date. As such, the rise in generic drug production is spurring the expansion of the superdisintegrants market.
Which Sub-Segments Are Driving Growth Within The Superdisintegrants Market?
The superdisintegrantsmarket covered in this report is segmented –
1) By Type: Natural Superdisintegrants; Synthetic Superdisintegrants; Other Superdisintegrants
2) By Formulation: Tablets; Capsules
3) By Therapeutic Area: Gastrointestinal Diseases; Neurological Diseases; Oncology; Infectious Diseases; Cardiovascular Diseases; Hematological Diseases
Subsegments:
1) By Natural Superdisintegrants: Starch; Cellulose; Chitosan; Gums; Other Natural Superdisintegrants
2) By Synthetic Superdisintegrants: Cross-linked Polyvinylpyrrolidone (Crospovidone); Sodium Starch Glycolate; Croscarmellose Sodium; Other Synthetic Superdisintegrants
3) By Other Superdisintegrants: Ion Exchange Resins; Surfactant-Based Superdisintegrants; Other Specialized Superdisintegrants
What Future-Focused Trends Are Anticipated In The Superdisintegrants Market?
In the superdisintegrants market, major companies are launching multifunctional disintegrants that improve drug formulation efficiency by combining disintegration, binding, and flow-enhancing properties. These excipients boost tablet disintegration speed and support patient compliance. For example, in June 2023, US company Ashland Inc. released Polyplasdone Plus, a co-processed multifunctional superdisintegrant that enhances tablet hardness and powder flow, simplifying production and enabling high-speed, continuous manufacturing.
Which Companies Hold A Competitive Edge In The 1511 Market?
Major companies operating in the superdisintegrants market are BASF SE, Merck KGaA, DuPont de Nemours Inc., IFF Pharma Solutions, Ingredion Incorporated, Roquette Freres SA., FMC Corporation, Azelis Group, Ashland Inc., Piramal Healthcare, Colorcon Inc. Ltd., Boai NKY Pharmaceuticals Ltd., JRS Pharma, Faran Shimi Pharmaceutical, DFE Pharma India Private Limited., Sigachi Industries Limited, Corel Pharma Chem, Maple Biotech Pvt. Ltd., Shanghai Chineway Pharmaceutical Technology Co. Ltd., JH Nanhang Life Sciences Co. Ltd.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/superdisintegrants-global-market-report
Which Region Dominates The Superdisintegrants Market Today?
North America was the largest region in the superdisintegrants market in 2024. The regions covered in the superdisintegrants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=21292&type=smp
Browse Through More Reports Similar to the Global Superdisintegrants Market 2025, By The Business Research Company
Pharmaceutical Api Manufacturing Global Market Report 2025
Generic Pharmaceuticals Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report
Pharmaceutical Sterility Testings Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
